PMID- 7788612
OWN - NLM
STAT- MEDLINE
DCOM- 19950727
LR  - 20190516
IS  - 0706-7437 (Print)
IS  - 0706-7437 (Linking)
VI  - 40
IP  - 2
DP  - 1995 Mar
TI  - [Atypical depression: evolution toward a specific pharmacologic and efficacious 
      treatment?].
PG  - 102-8
AB  - The present article reviews different concepts of atypical depression. Of these, 
      major depression associated with panic disorder would have a specific meaning 
      according to some pharmacological and prognosis studies. It seems that this type 
      of depression is quite frequent and has a significantly worse prognosis than 
      major depression alone. Controlled studies comparing the efficacy of tricyclic 
      antidepressants to phenelzine concluded in favour of the latter in general. It is 
      generally thought that atypical depression would respond better to monoamine 
      oxidase inhibitors (MAOI), but it would seem that it is mainly major depression 
      associated with panic disorder that could predict this kind of response to 
      treatment. Second generation antidepressants have not been studied systematically 
      for this purpose even though preliminary reports seem promising.
FAU - Dassylva, B
AU  - Dassylva B
AD  - Institut Philippe Pinel de Montreal, Quebec.
FAU - Fontaine, R
AU  - Fontaine R
LA  - fre
PT  - Comparative Study
PT  - English Abstract
PT  - Journal Article
PT  - Review
TT  - Depression atypique: evolution vers un traitement pharmacologique specifique et 
      efficace?
PL  - United States
TA  - Can J Psychiatry
JT  - Canadian journal of psychiatry. Revue canadienne de psychiatrie
JID - 7904187
RN  - 0 (Antidepressive Agents)
RN  - 0 (Antidepressive Agents, Tricyclic)
RN  - 0 (Monoamine Oxidase Inhibitors)
RN  - O408N561GF (Phenelzine)
SB  - IM
MH  - Antidepressive Agents/adverse effects/*therapeutic use
MH  - Antidepressive Agents, Tricyclic/therapeutic use
MH  - Controlled Clinical Trials as Topic
MH  - Depressive Disorder/classification/*drug therapy/psychology
MH  - Humans
MH  - Monoamine Oxidase Inhibitors/therapeutic use
MH  - Panic Disorder/classification/*drug therapy/psychology
MH  - Phenelzine/therapeutic use
MH  - Prognosis
RF  - 35
EDAT- 1995/03/01 00:00
MHDA- 1995/03/01 00:01
CRDT- 1995/03/01 00:00
PHST- 1995/03/01 00:00 [pubmed]
PHST- 1995/03/01 00:01 [medline]
PHST- 1995/03/01 00:00 [entrez]
AID - 10.1177/070674379504000209 [doi]
PST - ppublish
SO  - Can J Psychiatry. 1995 Mar;40(2):102-8. doi: 10.1177/070674379504000209.